Transforming the
basic biomedical knowledge
into economic and social value

Archivel Pharma will expand its efforts to produce biotech drugs for others. Luis Ruiz-Avila, the chief executive, explained it. The company opens up a new line of business to fund research into their blockbuster, Ruti, a vaccine against tuberculosis, which expects to enter phase III trials in large groups of patients, next year.